Publication of 2014 Reference Document and Annual Report
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced the publication of its 2014 Reference Document and Annual Report.
The 2014 Reference Document, registered this day with the French Market Authorities (Autorité des Marchés Financiers), is available to the public free of charge upon request as per current legal regulations at Onxeo’s headquarters - 49 Boulevard du Général Martial Valin, 75015 Paris - and may be consulted on the company’s website at https://www.onxeo.com/en/investisseurs/.
The annual financial report, the report of the Chairman of the Board of Directors on corporate governance and on internal control and risk management procedures, as well as the related auditors' report, Information on the fees paid to the statutory auditors in 2014, are included in this Reference Document.
Additionnally, Onxeo’s 2014 Annual Report is also available on the Company’s website at https://www.onxeo.com/en/investisseurs/.